US pharmacy pricing
Prohance Prices at US Pharmacies
Lowest price found · US pharmacies
$9.44/fill
for Gadoteridol, across the pharmacies in our data
US pharmacy prices — 5ml of 279.3mg/ml
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
| $9.44Lowest | $12.44 | $23.19 | |
| $13.64 | $16.64 | $23.19 | |
| $14.24 | $17.24 | $23.19 | |
| $14.24 | $17.24 | $23.19 | |
| $18.23 | $21.23 | $23.19 | |
| $18.23 | $21.23 | $23.19 | |
| $20.22 | $23.22 | $23.19 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Frequently asked questions
Is Gadoteridol (Prohance) expensive if I don't have insurance?
Our most recent US pharmacy data shows a low of roughly $9.44 for Gadoteridol with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.
Does Gadoteridol have a generic equivalent?
Generic and brand-name pricing for Gadoteridol is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
How much will Prohance cost with my health insurance?
The cost of Prohance with insurance depends entirely on the details of your specific health plan, including whether the drug is on your formulary, your deductible status, and your co-pay or coinsurance requirements. You should contact your insurance provider directly for precise coverage information. If your insurance does not cover Prohance, or if you have a high co-pay, you may explore alternative savings options such as manufacturer savings programs or pharmacy discount cards to potentially lower your cost. Patients with Medicare or Medicaid should also check their plan's formulary for coverage details.
Is a generic version of Prohance currently sold?
Prohance is a brand-name medication produced by Bracco Diagnostics. As of now, there is no FDA-approved generic equivalent available in the United States.